159 related articles for article (PubMed ID: 35305973)
1. OAS1, OAS2, and OAS3 Contribute to Epidermal Keratinocyte Proliferation by Regulating Cell Cycle and Augmenting IFN-1‒Induced Jak1‒Signal Transducer and Activator of Transcription 1 Phosphorylation in Psoriasis.
Huang YZ; Zheng YX; Zhou Y; Xu F; Cui YZ; Chen XY; Wang ZY; Yan BX; Zheng M; Man XY
J Invest Dermatol; 2022 Oct; 142(10):2635-2645.e9. PubMed ID: 35305973
[TBL] [Abstract][Full Text] [Related]
2. Quantitative Proteomic Profile of Psoriatic Epidermis Identifies OAS2 as a Novel Biomarker for Disease Activity.
Zhou Y; Wang P; Yan BX; Chen XY; Landeck L; Wang ZY; Li XX; Zhang J; Zheng M; Man XY
Front Immunol; 2020; 11():1432. PubMed ID: 32849499
[TBL] [Abstract][Full Text] [Related]
3. MALAT1 is involved in type I IFNs-mediated systemic lupus erythematosus by up-regulating OAS2, OAS3, and OASL.
Gao F; Tan Y; Luo H
Braz J Med Biol Res; 2020; 53(5):e9292. PubMed ID: 32321151
[TBL] [Abstract][Full Text] [Related]
4. Activation of RNase L in Egyptian Rousette Bat-Derived RoNi/7 Cells Is Dependent Primarily on OAS3 and Independent of MAVS Signaling.
Li Y; Dong B; Wei Z; Silverman RH; Weiss SR
mBio; 2019 Nov; 10(6):. PubMed ID: 31719180
[TBL] [Abstract][Full Text] [Related]
5. OAS1, 2, and 3: Significance During Active Tuberculosis?
Leisching G; Wiid I; Baker B
J Infect Dis; 2018 Apr; 217(10):1517-1521. PubMed ID: 29452387
[TBL] [Abstract][Full Text] [Related]
6. Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes.
Kanda N; Watanabe S
Endocrinology; 2007 May; 148(5):2317-25. PubMed ID: 17255201
[TBL] [Abstract][Full Text] [Related]
7. Activation of RNase L is dependent on OAS3 expression during infection with diverse human viruses.
Li Y; Banerjee S; Wang Y; Goldstein SA; Dong B; Gaughan C; Silverman RH; Weiss SR
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2241-6. PubMed ID: 26858407
[TBL] [Abstract][Full Text] [Related]
8.
Ma Y; Kim BH; Yun SK; Roh YS
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838711
[TBL] [Abstract][Full Text] [Related]
9. Podoplanin expression in wound and hyperproliferative psoriatic epidermis: regulation by TGF-β and STAT-3 activating cytokines, IFN-γ, IL-6, and IL-22.
Honma M; Minami-Hori M; Takahashi H; Iizuka H
J Dermatol Sci; 2012 Feb; 65(2):134-40. PubMed ID: 22189341
[TBL] [Abstract][Full Text] [Related]
10. OAS1, OAS2 and OAS3 restrict intracellular M. tb replication and enhance cytokine secretion.
Leisching G; Cole V; Ali AT; Baker B
Int J Infect Dis; 2019 Mar; 80S():S77-S84. PubMed ID: 30822544
[TBL] [Abstract][Full Text] [Related]
11. IFN-β1b induces OAS3 to inhibit EV71 via IFN-β1b/JAK/STAT1 pathway.
Zheng B; Zhou X; Tian L; Wang J; Zhang W
Virol Sin; 2022 Oct; 37(5):676-684. PubMed ID: 35934228
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.
Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB
J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222
[TBL] [Abstract][Full Text] [Related]
13. OASs in Defense of Mycobacterial Infection: Angels or Demons?
Zhang W; Cao X; Cao G; Chen X
Curr Issues Mol Biol; 2021; 40():221-230. PubMed ID: 32609093
[TBL] [Abstract][Full Text] [Related]
14. Uridine phosphorylase-1 promotes cell viability and cell-cycle progression in human epidermal keratinocytes via the glycolytic pathway.
Xiao X; Qiu T; Cheng Q; Wang W; Fan C; Zuo F
Clin Exp Pharmacol Physiol; 2024 Jul; 51(7):e13874. PubMed ID: 38797519
[TBL] [Abstract][Full Text] [Related]
15. STAT1 expression and activation is increased in lesional psoriatic skin.
Hald A; Andrés RM; Salskov-Iversen ML; Kjellerup RB; Iversen L; Johansen C
Br J Dermatol; 2013 Feb; 168(2):302-10. PubMed ID: 23013371
[TBL] [Abstract][Full Text] [Related]
16. Selective Immunomodulation of Inflammatory Pathways in Keratinocytes by the Janus Kinase (JAK) Inhibitor Tofacitinib: Implications for the Employment of JAK-Targeting Drugs in Psoriasis.
Morelli M; Scarponi C; Mercurio L; Facchiano F; Pallotta S; Madonna S; Girolomoni G; Albanesi C
J Immunol Res; 2018; 2018():7897263. PubMed ID: 30581877
[TBL] [Abstract][Full Text] [Related]
17. GATA3 expression is decreased in psoriasis and during epidermal regeneration; induction by narrow-band UVB and IL-4.
Rácz E; Kurek D; Kant M; Baerveldt EM; Florencia E; Mourits S; de Ridder D; Laman JD; van der Fits L; Prens EP
PLoS One; 2011; 6(5):e19806. PubMed ID: 21611195
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of JAK1/STAT3 pathway by 2-methoxyestradiol ameliorates psoriatic features in vitro and in an imiquimod-induced psoriasis-like mouse model.
Tang J; Liu C; Liu S; Zhou X; Lu J; Li M; Zhu L
Eur J Pharmacol; 2022 Oct; 933():175276. PubMed ID: 36130639
[TBL] [Abstract][Full Text] [Related]
19. Genomic structure of the mouse 2',5'-oligoadenylate synthetase gene family.
Kakuta S; Shibata S; Iwakura Y
J Interferon Cytokine Res; 2002 Sep; 22(9):981-93. PubMed ID: 12396720
[TBL] [Abstract][Full Text] [Related]
20. IL-17A upregulates keratin 17 expression in keratinocytes through STAT1- and STAT3-dependent mechanisms.
Shi X; Jin L; Dang E; Chang T; Feng Z; Liu Y; Wang G
J Invest Dermatol; 2011 Dec; 131(12):2401-8. PubMed ID: 21796151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
